Today, Stephen Takacsy, B. Eng, MBA commented about whether SJ-T, JWEL-T, SIS-T, MRU-T, L-T, EMP.A-T, AQN-T, ALA-T, BCE-T, QTRH-T, CWB-T, TD-T, NA-T, RY-T, BMO-T, BLX-T, NPI-T, T-T, QBR.B-T, PLC-T, TCS-T, VLN-T, BYL-T, RCH-T, DWS-X, LAS.A-T are stocks to buy or sell.
Very experienced team now running the company. Insider buying. Solely focused on intelligent transportation solutions. Biggest market share in US for electronic tolls. Sitting on a ton of data analytics, looking to monetize. Wouldn't hesitate to buy on this pullback.
Great infrastructure asset. The industry will be consolidating, especially by private equity.
Won't be another Nortel, but whether the dividend is safe is a good question. He sold mainly on concerns about growth. Shocked market with risky US acquisition, rather than paying down debt to make dividend more sustainable. Management forgot who their shareholders are, those wanting safe income.
Says dividend is on hold, which smells as though it'll be cut in the next year or so. Pitiful share price indicates that market's pricing this in. Yield is over 10%.
He owns Telus and QBR.B.
Leader in home accessibility and patient handling products. Benefits from aging demographics. Phenomenal results, increased margins. Over 18% EBITDA margins YTD.
Stock's down on tariff threat, big overreaction. Buying opportunity. Patient handling products are all made in USA, and most home accessibility is FDA-approved (tariff exempt). Home elevator business may not be exempt, but could easily shift manufacturing to another of its 12 plants worldwide. Yield is 3%.
Huge margins and free cashflow. Growing business annually compounded at over 15%. International expansion. US acquisition is growing double digits. Online China business growing 80%. Never been cheaper at 17x forward PE. Takeover potential in a few years. Yield is 2%.
(Analysts’ price target is $40.82)
By far, best performer in the space. Great growth in EBITDA, good balance sheet, great management.